NCT02549469 - Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Pain

Interventions

DRUG

Naproxen Sodium ER (BAY117031), 20% HPMC

1 tablet 660 mg administered orally once daily

DRUG

Naproxen Sodium ER (BAY117031), 30% HPMC

1 tablet 660 mg administered orally once daily

DRUG

Naproxen Sodium ER (BAY117031), 40% HPMC

1 tablet 660 mg administered orally once daily

DRUG

Aleve (Naproxen Sodium, BAY117031)

1 tablet 220 mg administered orally three times daily